This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Free Reports

A Safer Way to Play the Drug Sector

02/26/08 - 06:16 AM EST

Contract research organizations aren't without risks of course, but they do offer some protection against the vagaries of the industry.

Shares rise 5.4% on the news.

Reasons to Believe in Schering-Plough

02/11/08 - 02:05 PM EST

Despite the Vytorin setback, the focus here should be on drugs in development, not products in the market.

Big Pharma Moving More Work Offshore

01/25/08 - 02:06 PM EST

Merck, Pfizer and others are getting used to a new world that requires cost discipline.

If a recession can be avoided, 2008, like last year, could be active for initial issues.

Several firms are debating whether to bulk up or shed lower-margin units.

Here's what you need to know about buying these rare, tradition-rich pieces from the Canadian islands.

No Easy Fix for Pfizer

11/29/07 - 02:14 PM EST

It can be done, but it will probably require some tough choices.

Is Mylan Cheap Yet?

11/28/07 - 03:14 PM EST

Shares have dropped more than 30% since May, but questions remain about its model.

Cephalon Still a Stressor

11/06/07 - 04:04 PM EST

Will that change when earnings arrive Thursday?

Page 2 of 147
Top Rated Stocks Top Rated Funds Top Rated ETFs